Stradling Client Tandem Diabetes Announces FDA Approval

San Diego-based Tandem Diabetes Care announces FDA clearance of the T:SLIM Insulin Delivery System. It is said to be the smallest insulin pump system and first-ever with a touch screen. For more information, please read the press release.

Stradling shareholder and director Bruce Feuchter serves as the organization's outside general counsel.